Obagi Medical Products shares are trading on heavy volume today, having risen 0.2% to $12.89. About 266,000 shares have been traded today, as compared to the 30-day average volume of 209,000 shares. Spikes in volume can validate a breakout or signify a potential turning point.
Over the past year, Obagi Medical Products has traded in a range of $8.61 to $18.00 and is now at $12.89, 50% above that low. The 200-day and 50-day moving averages have moved 0.26% higher and 0.28% lower over the past week, respectively.
Potential upside of 12.5% exists for Obagi Medical Products, based on a current level of $12.89 and analysts' average consensus price target of $14.50. The stock should find resistance at its 200-day moving average (MA) of $12.95, as well as support at its 50-day MA of $12.67.
Obagi Medical Products, Inc. develops skin care pharmaceuticals. The Company develops prescription topical treatments for premature aging, photo-damage, hyperpigmentation, acne, and soft tissue deficits such as fine lines and wrinkles.